Pages that link to "Q35044513"
Jump to navigation
Jump to search
The following pages link to Antiviral effect on MS-2 coliphage obtained with a synthetic antigen (Q35044513):
Displaying 36 items.
- Turns in peptides and proteins (Q28282176) (← links)
- The Impact of New Technologies on Vaccine Development (Q30411839) (← links)
- Tapping the immunological repertoire to produce antibodies of predetermined specificity (Q30412042) (← links)
- Viral pathogenesis and molecular biology (Q34073902) (← links)
- Peptide antibodies: new tools for cell biology (Q34387713) (← links)
- Genetic variability: The key problem in the prevention and therapy of RNA‐based virus infections (Q35112794) (← links)
- Immunity and protection against influenza virus by synthetic peptide corresponding to antigenic sites of hemagglutinin (Q36257657) (← links)
- Anti-influenza response achieved by immunization with a synthetic conjugate (Q36278500) (← links)
- Hepatitis B virus vaccine: identification of HBsAg/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immunogenic peptide (Q36278570) (← links)
- Successful immunization with a totally synthetic diphtheria vaccine (Q36308543) (← links)
- Antiviral response elicited by a completely synthetic antigen with built-in adjuvanticity (Q36416339) (← links)
- Both cholera toxin-induced adenylate cyclase activation and cholera toxin biological activity are inhibited by antibodies against related synthetic peptides (Q37580591) (← links)
- Antibodies against synthetic peptides of the B subunit of cholera toxin: crossreaction and neutralization of the toxin (Q37690884) (← links)
- The rational development of molecularly imprinted polymer-based sensors for protein detection (Q37816234) (← links)
- Peptides: chemistry, biology, and pharmacology (Q38014963) (← links)
- Synthetic T and B cell recognition sites: implications for vaccine development (Q38665396) (← links)
- Adjuvant effect of a peptidoglycan attached covalently to a synthetic antigen provoking anti-phage antibodies (Q39628409) (← links)
- Scope of DNA cloning and chemical methods in development of chemotherapeutic agents (Q40076283) (← links)
- Synthetic peptides and purified antigens as vaccines. (Q40388010) (← links)
- The Leeuwenhoek Lecture, 1993. Peptide vaccines: dream or reality? (Q40392424) (← links)
- Need for cellular and humoral immune responses in bovines to ensure protection from foot-and-mouth disease virus (FMDV)--a point of view (Q40640674) (← links)
- Engineered human vaccines (Q40754536) (← links)
- Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus (Q41308046) (← links)
- Viral vaccines: the use of currently available products and future developments (Q41449981) (← links)
- A poliovirus type 1 neutralization epitope is located within amino acid residues 93 to 104 of viral capsid polypeptide VP1 (Q41464907) (← links)
- Structural and immunological characterization of Friend murine leukaemia virus glycopolypeptide using synthetic oligopeptides. (Q41578447) (← links)
- Hedgehog and its patched-smoothened receptor complex: a novel signalling mechanism at the cell surface (Q41581685) (← links)
- Antibodies That React with Predetermined Sites on Proteins (Q43560329) (← links)
- Recent Advances in Vaccine Technologies (Q47318218) (← links)
- The potential of retro-inverso peptides as synthetic vaccines. (Q53852768) (← links)
- Characterization of an intergroup serological mutant from group II RNA phage GA. (Q54436206) (← links)
- Synthetic Antigens and Vaccines (Q58352976) (← links)
- Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides (Q59094245) (← links)
- Developing synthetic vaccines (Q70276041) (← links)
- Synthetic peptides as the basis for future vaccines (Q72668724) (← links)
- From proteins and protein models to their use in immunology and immunotherapy (Q78758261) (← links)